MetrioPharm AG

Bleicherweg 45
Zurich
8002
Germany

Tel: 41-44-515-21-97
Fax: 41-44-201-74-75

Show jobs for this employer

About MetrioPharm AG

MetrioPharm AG is a biotech company developing oral drug compounds for the treatment of autoimmune and other inflammatory diseases. MetrioPharm’s MP1000 pipeline consists of small molecule immune modulators for unmet medical needs in Immune-Mediated Inflammatory Diseases (IMIDs).
YEAR FOUNDED:
2007
LEADERSHIP:
Founder and CEO: Wolfgang Brysch
Founder and COO: Ekkehard Brysch
CFO: Holger Dunker
CLINICAL TRIAL:
Please click here for clinical trial information.

5 articles with MetrioPharm AG